Journal profile · PHARMACOLOGY & PHARMACY
Journal of Pharmacology & Pharmacotherapeutics
ISSN 0976-500X · eISSN 0976-5018 · Wolters Kluwer Health
Journal of Pharmacology & Pharmacotherapeutics: CAS Zone 4 · Medicine (2025 upgraded edition); subscription journal; APC about USD 800; 64 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Journal of Pharmacology & Pharmacotherapeutics is published by Wolters Kluwer Health and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pharmacovigilance and Adverse Drug Reactions, Pharmacy and Medical Practices and Drug-Induced Adverse Reactions, together about 30.2% of its articles. Its main subfields are Pharmacology. (generated from OpenAlex topic counts and CAS ranking data)
Indian Journal of Pharmaceutical Education and Research (IJPER) is the official journal of the Association of Pharmaceutical Teachers of India (APTI) and has been published since 1967. IJPER is a quarterly publication devoted to publishing reviews and research articles in pharmacy and the related disciplines of pharmaceutical education. It covers articles of special interest across pharmaceutical research, teaching and learning, laboratory innovations, education technology, curriculum design, examination reforms, training and other related issues, and encourages debate and discussion on issues of vital importance to pharmaceutical education and research. The journal is circulated and referred to by more than 6,000 teachers, 40,000 students and over 1,000 professionals working in pharmaceutical industries, regulatory departments, hospitals and related fields. Editor-in-Chief Dr. Milind Janrao UmekarPrincipal & Professor, Smt. Kishoritai Bhoyar College of PharmacyBehind Railway Station, New Kamptee, Nagpur-441002, Maharashtra, IndiaEmail: editor@ijper.org Article types Research Articles — original research papers in pharmaceutical sciences and related fields. Review Articles — comprehensive reviews on current topics in pharmaceutical sciences. Abstracting & indexing IJPER is indexed and abstracted in Web of Science, Science Citation Index Expanded, SCOPUS, Scimago Journal Ranking, ABC Chemistry, African Index Medicus, Connect Journals, the Geneva Foundation for Medical Education and Research (GFMER), Google Scholar, NewJour (Georgetown University Library, USA), OpenJGate, Pharmaceutical Sciences Open Access Resources (PSOAR), Science Central, Ulrichsweb, Indian Science Abstracts, Medicinal and Aromatic Plants Abstracts (MAPA), and HINARI.
From the journal's Aims & Scope
Research area (LetPub): PHARMACOLOGY & PHARMACY
Editor-in-chief Milind JanraoPublisher website
Editorial board by country: none in mainland China; most named India 4, Algeria 1 (5 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmacovigilance and Adverse Drug ReactionsPharmacology, Toxicology and Pharmaceutics14.3%
- Pharmacy and Medical PracticesPharmacology, Toxicology and Pharmaceutics9.1%
- Drug-Induced Adverse ReactionsMedicine6.9%
- Pharmaceutical Practices and Patient OutcomesMedicine6.7%
- Pharmaceutical industry and healthcarePharmacology, Toxicology and Pharmaceutics4.8%
- Pharmaceutical studies and practicesMedicine4.8%
- Pharmaceutical Economics and PolicyEconomics, Econometrics and Finance4.2%
- Anesthesia and Pain ManagementMedicine4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Pharmacology (medical) | Q3 | 194/278 | 30th |
| Pharmacology | Q4 | 247/328 | 24th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
SCIEWeb of SciencePublisher website
Other: Index Medicus, Google Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 1.8LetPub ·
- CiteScore (publisher) 2025
- 1.6Publisher website ·
- SJR 2026-06
- 0.27LetPub ·
- SNIP 2026-06
- 0.42LetPub ·
- h-index
- 58OpenAlex ·
- i10-index
- 281OpenAlex ·
- 2-year mean citedness
- 3.4OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 97.56%LetPub ·
Volume
- Articles per year
- 61LetPub ·
Articles by year OpenAlex count · 917 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 35 | 35 | 1,295 |
| 2025 | 64 | 64 | 2,528 |
| 2024 | 69 | 69 | 2,647 |
| 2023 | 36 | 36 | 2,595 |
| 2022 | 50 | 50 | 2,597 |
| 2021 | 26 | 10 | 3,022 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Peer review
- Single-anonymous peer reviewPublisher website · model-extracted
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 800 | — | — | |
| Publisher website | INR 500 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare9 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≤ 6
- Reference style
- Vancouver
- Templates
- Word
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional
- Highlights
- Optional
- Graphical abstract
- Optional
- Cover letter
- Required
Policy excerpts from the journal's websiteAuthorship, Publication ethics, Plagiarism
- Authorship
Original work only; no simultaneous submission. Model summary
Submission of a manuscript implies that the same work has not been published, or is not under consideration for publication, in another journal.
Source ↗Publisher website ·- Publication ethics
Ethics approval required for in-vivo experiments involving animals or humans. Model summary
Authors reporting in-vivo experiments involving animals or humans should state whether due permission was obtained from the relevant authorities, ethics committee, or institutional review board.
Source ↗Publisher website ·- Plagiarism Plagiarism policy
Plagiarism screening with iThenticate before peer review; plagiarised content exceeding 10–15% will not be considered or will be asked to be revised. Model summary
IJPER is committed to publishing original, plagiarism-free work. All submitted articles are screened for plagiarised content (iThenticate) before being sent for peer review. An article not cleared in the plagiarism analysis, with plagiarised content exceeding 10–15%, will not be considered or will be asked to be revised accordingly; the decision rests with the handling editor. If you already have …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wolters Kluwer Health
- ISSN
- 0976-500X
- Electronic ISSN
- 0976-5018
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Journal of Pharmacology & Pharmacotherapeutics
What CAS zone is Journal of Pharmacology & Pharmacotherapeutics in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Pharmacology & Pharmacotherapeutics is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What are the manuscript requirements of Journal of Pharmacology & Pharmacotherapeutics?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≤ 6; Reference style: Vancouver; Templates: Word; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional; Highlights: Optional; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Pharmacology & Pharmacotherapeutics based?
Of the 5 board members whose country the journal's board page names, none are in mainland China; the countries named most often are India (4) and Algeria (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Pharmacology & Pharmacotherapeutics?
According to LetPub and DOAJ records, Journal of Pharmacology & Pharmacotherapeutics is indexed in ESCI and Scopus. The journal's website also lists SCIE and Web of Science; that list has not been checked against each database.
Is Journal of Pharmacology & Pharmacotherapeutics open access, and what is the APC?
Journal of Pharmacology & Pharmacotherapeutics is a subscription journal. APC about USD 800.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .